Ulinastatin
- Generic Name
- Ulinastatin
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 80449-31-6
- Unique Ingredient Identifier
- OR3S9IF86U
- Background
Ulinastatin has been investigated for the prevention of Cardiovascular Disease and Adverse Reaction to Drug.
- Associated Conditions
- -
- Associated Therapies
- -
Efficacy of Ulinastatin for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients
- Conditions
- Interventions
- First Posted Date
- 2018-01-02
- Last Posted Date
- 2023-01-31
- Lead Sponsor
- Sun Yat-sen University
- Target Recruit Count
- 176
- Registration Number
- NCT03387774
- Locations
- 🇨🇳
Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong, China
Ulinastatin Improves Postoperative Oxygenation After Cardiopulmonary Bypass
- Conditions
- Interventions
- First Posted Date
- 2017-05-16
- Last Posted Date
- 2017-05-16
- Lead Sponsor
- Konkuk University Medical Center
- Target Recruit Count
- 80
- Registration Number
- NCT03154814
- Locations
- 🇰🇷
Konkuk University Medical Center, Seoul, Korea, Republic of
Prevention of Ulinastatin on Acute Respiratory Distress Syndrome (ARDS)
- Conditions
- Interventions
- First Posted Date
- 2017-03-24
- Last Posted Date
- 2024-01-24
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 840
- Registration Number
- NCT03089957
- Locations
- 🇨🇳
Beijing Shijitan Hospital Affiliated to Capital Medical University, Beijing, Beijing, China
🇨🇳Central Hospital of Zi Bo, Zibo, Shandong, China
🇨🇳CANGZHOU People's Hospital, Cangzhou, Hebei, China
The Safety and Dose Response Relationship of Ulinastatin for Acute Respiratory Distress Syndrome(ARDS)
- First Posted Date
- 2016-09-09
- Last Posted Date
- 2018-04-20
- Lead Sponsor
- Techpool Bio-Pharma Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT02895191
- Locations
- 🇨🇳
Guangzhou First People's Hospital, Guangzhou, Guangdong, China
🇨🇳Huadong Hospital,Fudan University, Shanghai, Shanghai, China
🇨🇳First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
Ulinastatin Treatment in Adult Patients With Sepsis and Septic Shock in China
- First Posted Date
- 2016-01-06
- Last Posted Date
- 2022-10-13
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 347
- Registration Number
- NCT02647554
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Ulinastatin Injection in in Pediatric Patients Undergoing Open Heart Surgery
- First Posted Date
- 2015-08-19
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- Techpool Bio-Pharma Co., Ltd.
- Target Recruit Count
- 450
- Registration Number
- NCT02527811
- Locations
- 🇨🇳
General Hospital of Guangzhou Millitary Command, Guangzhou, Guangdong, China
🇨🇳Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China
🇨🇳Shanghai Children's Medical Center, Shanghai, China
Post-market Safety Reassessment of Ulinastatin for Injection
- Conditions
- Interventions
- First Posted Date
- 2015-08-13
- Last Posted Date
- 2018-04-23
- Lead Sponsor
- Techpool Bio-Pharma Co., Ltd.
- Target Recruit Count
- 10000
- Registration Number
- NCT02520570
- Locations
- 🇨🇳
Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, China
Effect of Ulinastatin on Postoperative Renal Function in Patients Undergoing Robot-assisted Laparoscopic Partial Nephrectomy
- First Posted Date
- 2014-10-08
- Last Posted Date
- 2016-08-25
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 66
- Registration Number
- NCT02258906
- Locations
- 🇰🇷
Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of
Mechanism and Early Intervention Research on ALI During Emergence Surgery of Acute Stanford A Aortic Dissection
- Conditions
- Interventions
- First Posted Date
- 2013-07-10
- Last Posted Date
- 2014-01-24
- Lead Sponsor
- Beijing Anzhen Hospital
- Target Recruit Count
- 220
- Registration Number
- NCT01894334
Ulinastatin Preventing Postoperative Hepatic Failure in Hepatocellular Carcinoma (HCC)
- Conditions
- Interventions
- First Posted Date
- 2012-07-18
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT01643447
- Locations
- 🇨🇳
Eastern Hepatobiliary Surgery Hospital, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.